颅内硬脑膜动静脉瘘在颅内出血后的早期再出血
本研究回顾性分析21例以颅内出血起病的硬脑膜动静脉瘘(DAVF)患者,按出血类型分为单纯脑实质出血(pIPH)组13例与非单纯脑实质出血(non-pIPH)组8例。non-pIPH组早期再出血率显著高于pIPH组(p=0.012),静脉扩张(p=0.005)和直接皮质静脉引流(p=0.008)在non-pIPH组比例更高。作者认为所有DAVF伴颅内出血者均需早期治疗,non-pIPH伴静脉扩张或直接皮质静脉引流者再出血风险更高,需谨慎关注并紧急治疗。
要点
- 21例DAVF伴颅内出血患者中,再出血发生8例(38.1%)。
- non-pIPH组8例中4例(50%)在3天内发生早期再出血,pIPH组无早期再出血,组间差异显著(p=0.012)。
- 静脉扩张(p=0.005)和直接皮质静脉引流(p=0.008)在non-pIPH组比例显著高于pIPH组。
核心结论
- DAVF伴颅内出血者在首次出血后可能再出血,因此所有DAVF伴颅内出血者可能需要早期治疗。
- 以non-pIPH起病且初始血管造影显示静脉扩张或直接皮质静脉引流的DAVF,早期再出血风险可能更高。
- 作者认为对这类患者需谨慎关注并紧急治疗。
研究设计与样本
- 回顾性分析21例以颅内出血起病的硬脑膜动静脉瘘(DAVF)患者的临床与影像学特征。
- 出血类型分为单纯脑实质出血(pIPH)与非单纯脑实质出血(non-pIPH,即蛛网膜下腔或硬膜下出血伴脑实质出血)。
主要发现
- pIPH组13例,non-pIPH组8例。
- 中位随访30个月(范围1-116个月),从出血至治疗的中位间隔为4天(范围0-72天)。
- 21例中再出血8例(38.1%)。
- non-pIPH组8例中4例(50%)在3天内发生早期再出血,pIPH组无早期再出血,non-pIPH组早期再出血率显著更高(p=0.012)。
- 血管造影上,静脉扩张(p=0.005)和直接皮质静脉引流(p=0.008)在non-pIPH组的比例显著高于pIPH组。
临床怎么用
- 作者认为所有DAVF伴颅内出血者可能需要早期治疗。
- 作者认为以non-pIPH起病且初始血管造影显示静脉扩张或直接皮质静脉引流的患者,需谨慎关注并紧急治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to evaluate the clinical and angiographic characteristics of dural arteriovenous fistulas (DAVF) presenting with intracranial hemorrhage (ICH), with a focus on early rebleeding according to the initial hemorrhage type. METHOD: The clinical and radiologic features of 21 dAVFs that presented with intracranial hemorrhage were retrospectively reviewed. The hemorrhage type was classified as pure intraparenchymal hemorrhage (pIPH) and subarachnoid or subdural hemorrhage with IPH (non-pIPH). RESULTS: There were 13 patients with pIPH and 8 with non-pIPH. The median follow-up period was 30 months (range, 1-116 months), and the median interval from hemorrhage to treatment was 4 days (range, 0-72 days). Rebleeding occurred in 8 (38.1%) of 21 patients. Four (50%) of eight patients with non-pIPH suffered from early rebleeding within 3 days, while there was no early rebleeding in patients with pIPH. There was a significantly higher rate of early rebleeding in the non-pIPH group (p = 0.012). Angiographically, venous ectasia (p = 0.005) and direct cortical venous drainage (dCVD) (p = 0.008) showed a significantly higher proportion in the non-pIPH group than in the pIPH group. CONCLUSIONS: DAVFs with ICH is likely to rebleed after the first hemorrhage. Thus, early treatment can be needed in all DAVFs with ICH. In addition, DAVFs that presenting with non-pIPH and containing venous ectasia or dCVD on initial angiography may have a higher risk of early rebleeding. Therefore, cautious attention and urgent treatment are necessary for these patients.
引用
- Choi JH, Jo KI, Kim KH, et al. Early rebleeding of intracranial dural arteriovenous fistulas after an intracranial hemorrhage. Acta Neurochir (Wien). 2017. PMID: 28567488. doi:10.1007/s00701-017-3226-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。